Dynamic metabolites profile of cerebral ischemia/reperfusion revealed by 1H NMR-based metabolomics contributes to potential biomarkers

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 7, 2014, Pages 4067-4075

  Wang, Yun ^a   Wang, Yi Gang ^a,b   Ma, Teng Fei ^a   Li, Mei ^a   Gu, Shu Ling ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b 215 Hospital of Shannxi Nuclear Industry   (China)

Author keywords

Biomarkers; Glycine; Ischemic stroke; Malonic acid; Metabolomic

Indexed keywords

BIOLOGICAL MARKER; GLYCINE; MALONIC ACID; MALONIC ACID DERIVATIVE;

ANIMAL; BLOOD; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; MALE; METABOLISM; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; GLYCINE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MALONATES; METABOLOMICS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; STROKE;

EID: 84906270831     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Rothwell PM, Algra A and Amarenco P. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet 2011; 377: 1681-1692.
2. Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, Ferriero D, Jones BV, Kirkham FJ, Scott RM and Smith ER. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardio-vascular Disease in the Young. Stroke 2008; 39: 2644-2691.
3. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, Clark W, Budzik R and Zaidat OO. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380: 1241-1249.
4. Eltzschig HK and Eckle T. Ischemia and reperfusion--from mechanism to translation. Nat Med 2011; 17: 1391-1401.
5. Doyle KP, Simon RP and Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology 2008; 55: 310-318.
6. Sacco RL, Chong JY, Prabhakaran S and Elkind MS. Experimental treatments for acute ischaemic stroke. Lancet 2007; 369: 331-341.
7. Unal-Cevik I, Kilinc M, Can A, Gursoy-Ozdemir Y and Dalkara T. Apoptotic and necrotic death mechanisms are concomitantly activated in the same cell after cerebral ischemia. Stroke 2004; 35: 2189-2194.
8. Sumbria RK, Klein J and Bickel U. Acute depression of energy metabolism after microdialysis probe implantation is distinct from ischemia-induced changes in mouse brain. Neurochem Res 2011; 36: 109-116.
9. Schurr A, Miller JJ, Payne RS and Rigor BM. An increase in lactate output by brain tissue serves to meet the energy needs of glutamate-activated neurons. J Neurosci 1999; 19: 34-39.
10. Melani A, Pantoni L, Corsi C, Bianchi L, Monopoli A, Bertorelli R, Pepeu G and Pedata F. Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage. Stroke 1999; 30: 2448-2454; discussion 2455.
11. Issaq HJ, Van QN, Waybright TJ, Muschik GM and Veenstra TD. Analytical and statistical ap proaches to metabolomics research. J Sep Sci 2009; 32: 2183-2199.
12. Dutta M, Joshi M, Srivastava S, Lodh I, Chakravarty B and Chaudhury K. A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis. Mol Biosyst 2012; 8: 3281-3287.
13. Nicholson JK and Lindon JC. Systems biology: Metabonomics. Nature 2008; 455: 1054-1056.
14. Yang M, Wang S, Hao F, Li Y, Tang H and Shi X. NMR analysis of the rat neurochemical changes induced by middle cerebral artery occlusion. Talanta 2012; 88: 136-144.
15. Jung JY, Lee HS, Kang DG, Kim NS, Cha MH, Bang OS, Ryu do H and Hwang GS. 1H-NMR-based metabolomics study of cerebral infarction. Stroke 2011; 42: 1282-1288.
16. Jiang Z, Sun J, Liang Q, Cai Y, Li S, Huang Y, Wang Y and Luo G. A metabonomic approach applied to predict patients with cerebral infarction. Talanta 2011; 84: 298-304.
17. Longa EZ, Weinstein PR, Carlson S and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91.
18. Wang Y, Wang Y, Li M, Gu T, Xu P, Ma T and Gu S.1H NMR-based Metabolomics Exploring Biomarkers in Rats Cerebralspinal Fluid After Cerebral Ischemia/Reperfusion. Mol Biosyst 2012.
19. Berger C, Xia F, Maurer MH and Schwab S. Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Res Rev 2008; 58: 48-56.
20. Khandelwal P, Beyer CE, Lin Q, Schechter LE and Bach AC 2nd. Studying rat brain neurochemistry using nanoprobe NMR spectroscopy: a metabonomics approach. Anal Chem 2004; 76: 4123-4127.
21. Teahan O, Gamble S, Holmes E, Waxman J, Nicholson JK, Bevan C and Keun HC. Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal Chem 2006; 78: 4307-4318.
22. Bijlsma S, Bobeldijk I, Verheij ER, Ramaker R, Kochhar S, Macdonald IA, van Ommen B and Smilde AK. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem 2006; 78: 567-574.
23. Um SY, Chung MW, Kim KB, Kim SH, Oh JS, Oh HY, Lee HJ and Choi KH. Pattern recognition analysis for the prediction of adverse effects by nonsteroidal anti-inflammatory drugs using 1H NMR-based metabolomics in rats. Anal Chem 2009; 81: 4734-4741.
24. Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, Nunez D, Sweatman BC, Haselden JN, Cox RD, Connor SC and Griffin JL. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 2007; 29: 99-108.
25. Zhang S, Zheng C, Lanza IR, Nair KS, Raftery D and Vitek O. Interdependence of signal processing and analysis of urine 1H NMR spectra for metabolic profiling. Anal Chem 2009; 81: 6080-6088.
26. Gu H, Pan Z, Xi B, Hainline BE, Shanaiah N, Asiago V, Gowda GA and Raftery D. 1H NMR metabolomics study of age profiling in children. NMR Biomed 2009; 22: 826-833.
27. Andreadou I, Papaefthimiou M, Zira A, Cons-tantinou M, Sigala F, Skaltsounis AL, Tsantili-Kakoulidou A, Iliodromitis EK, Kremastinos DT and Mikros E. Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein. NMR Biomed 2009; 22: 585-592.
28. Teng R, Junankar PR, Bubb WA, Rae C, Mercier P and Kirk K. Metabolite profiling of the intraerythrocytic malaria parasite Plasmodium falciparum by (1)H NMR spectroscopy. NMR Biomed 2009; 22: 292-302.
29. Viant MR, Lyeth BG, Miller MG and Berman RF. An NMR metabolomic investigation of early metabolic disturbances following traumatic brain injury in a mammalian model. NMR Biomed 2005; 18: 507-516.
30. Fiebach JB, Schellinger PD, Jansen O, Meyer M, Wilde P, Bender J, Schramm P, Juttler E, Oehler J, Hartmann M, Hahnel S, Knauth M, Hacke W and Sartor K. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 2002; 33: 2206-2210.
31. Murin R, Mohammadi G, Leibfritz D and Hamprecht B. Glial metabolism of valine. Neurochem Res 2009; 34: 1195-1203.
32. Atkinson W, Elmslie J, Lever M, Chambers ST and George PM. Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and postmethionine load conditions in healthy male subjects. Am J Clin Nutr 2008; 87: 577-585.
33. Rothman SM and Olney JW. Glutamate and the pathophysiology of hypoxic--ischemic brain damage. Ann Neurol 1986; 19: 105-111.
34. Gusev EI, Skvortsova VI, Dambinova SA, Raevskiy KS, Alekseev AA, Bashkatova VG, Kovalenko AV, Kudrin VS and Yakovleva EV. Neuroprotective effects of glycine for therapy of acute ischaemic stroke. Cerebrovasc Dis 2000; 10: 49-60.
35. Petrat F, Boengler K, Schulz R and de Groot H. Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischaemia-reperfusion injury: current knowledge. Br J Pharmacol 2012; 165: 2059-2072.
36. Oda M, Kure S, Sugawara T, Yamaguchi S, Kojima K, Shinka T, Sato K, Narisawa A, Aoki Y, Matsubara Y, Omae T, Mizoi K and Kinouchi H. Direct correlation between ischemic injury and extracellular glycine concentration in mice with genetically altered activities of the glycine cleavage multienzyme system. Stroke 2007; 38: 2157-2164.
37. Yao W, Ji F, Chen Z, Zhang N, Ren SQ, Zhang XY, Liu SY and Lu W. Glycine exerts dual roles in ischemic injury through distinct mechanisms. Stroke 2012; 43: 2212-2220.